Artal Group’s Olema Pharmaceuticals OLMA Stock Holding History

Artal Group’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-260,500	Closed	-$638K	–	134
2022 Q4	$638K	Hold	260,500	–	–	0.04%	115
2022 Q3	$719K	Hold	260,500	–	–	0.03%	121
2022 Q2	$1.06M	Hold	260,500	–	–	0.06%	115
2022 Q1	$1.11M	Hold	260,500	–	–	0.05%	122
2021 Q4	$2.44M	Hold	260,500	–	–	0.07%	126
2021 Q3	$7.18M	Hold	260,500	–	–	0.16%	97
2021 Q2	$7.29M	Hold	260,500	–	–	0.15%	108
2021 Q1	$8.64M	Hold	260,500	–	–	0.15%	103
2020 Q4	$12.5M	Buy	+260,500	New	+$12.2M	0.27%	83

Other funds holding OLMA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group's OLMA Position: Q1 2023 in Review

Artal Group sold out of Olema Pharmaceuticals (OLMA) in Q1 2023, closing a stake of 260,500 shares — an estimated $638K sold.

Artal Group first reported a position in OLMA in Q4 2020 and held it in 9 quarters. The position peaked at $12.5M in Q4 2020. 65 funds tracked by Wall St. Rank hold OLMA as of Q1 2023.

Artal Group reported no remaining Olema Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Artal Group sold 260,500 Olema Pharmaceuticals shares in Q1 2023, an estimated $638K.
Artal Group first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 9 quarters.
Artal Group's Olema Pharmaceuticals position peaked at $12.5M in Q4 2020.
65 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2023.

Based on Artal Group's 13F filing for Q1 2023, filed 12 May 2023.